US stocks face pressure from rising inflation worries while OpenAI teams up with Visa. Plus, America CarMart races to raise capital to stave off default.

#OpenAI #Visa #Inflation #Stocks #CarMart #Volvo #AutonomousDriving #FinanceNews

——–
Watch Bloomberg Radio LIVE on YouTube
Weekdays 7am-6pm ET
Saturday & Sunday 7am-10am ET
WATCH HERE: http://bit.ly/3vTiACF

Follow us on X: https://twitter.com/BloombergRadio

Subscribe to our Podcasts:

Bloomberg Daybreak: http://bit.ly/3DWYoAN
Bloomberg Surveillance: http://bit.ly/3OPtReI
Bloomberg Intelligence: http://bit.ly/3YrBfOi
Balance of Power: http://bit.ly/3OO8eLC
Bloomberg Businessweek: http://bit.ly/3IPl60i

Listen on Apple CarPlay and Android Auto with the Bloomberg Business app:
Apple CarPlay: https://apple.co/486mghI
Android Auto: https://bit.ly/49benZy

Visit our YouTube channels:
Bloomberg Podcasts: https://www.youtube.com/bloombergpodcasts
Bloomberg Television: https://www.youtube.com/@markets
Bloomberg Originals: https://www.youtube.com/bloomberg
Quicktake: https://www.youtube.com/@BloombergQuicktake

The post Bloomberg Money Minute : OpenAI Visa Pact, CarMart Credit Risk, Inflation Weighs on Stocks appeared first on MASSIVE News.

Watch Paul and Scarlet LIVE every day on YouTube: http://bit.ly/3vTiACF (http://bit.ly/3vTiACF).

Bloomberg Intelligence hosted by Paul Sweeney, Scarlet Fu, and John Tucker

-Dan Ives, Global Head of Technology Research at Wedbush Securities, discusses OpenAI becoming the third major artificial intelligence developer to confidentially file for a public listing, joining rivals in an IPO pipeline. The company is working with Goldman Sachs Group Inc. and Morgan Stanley on a potential listing as soon as the fall, according to people familiar with the matter.

-Carmen Arroyo, Bloomberg Tech Reporter, discusses the Bloomberg Big Take story: “SpaceX IPO Forces Investors to Bet on Musk’s Entangled AI Empire.” Elon Musk’s imperial approach has made it difficult to decipher his companies’ true valuations. With the SpaceX IPO looming, some investors have raised concerns about SpaceX’s accounting practices, corporate governance risks and related-party transactions with other Musk entities. And as Musk aims for the stars, some investors have grown anxious about whether his goals are attainable, or if he’s bending the rules to pursue them.

-Sam Fazeli, Bloomberg Intelligence, Director of Research for Global Industries and Senior Pharmaceuticals Analyst, discusses the latest in biotech sector. Eli Lilly & Co. presented data showing its next-generation shot, retatrutide, can help patients lose 30% of their body weight over about two years.

-Jennifer Rie, Bloomberg Intelligence Senior Litigation Analyst, discusses Britain’s merger watchdog opening a probe into Paramount Skydance Corp.’s $110 billion takeover of Warner Bros. Discovery Inc. The Competition and Markets Authority has set an initial deadline of August 7 to rule on the deal, which would unite two Hollywood studios and major news networks.
See omnystudio.com/listener (https://omnystudio.com/listener) for privacy information.

Paul Sweeney and the Bloomberg News team cover the day’s market action, with analysis from Bloomberg Intelligence analysts, Bloomberg Opinion writers and influential newsmakers.

Watch us LIVE on YouTube: https://youtube.com/live/f39oHo6vFLg

Subscribe to Bloomberg Podcasts: https://bit.ly/BloombergPodcasts
Listen to more Bloomberg Intelligence: https://www.youtube.com/playlist?list=PLe4PRejZgr0MfvtfGTYQIno9T-8l8nKFv

#News #Markets #Bloomberg #Podcast #Business #Finance

Visit us: https://www.bloomberg.com/podcasts

Follow Bloomberg Podcasts on Twitter: https://twitter.com/podcasts

Visit our other YouTube channels:
Bloomberg Television: https://www.youtube.com/@markets
Bloomberg Originals: https://www.youtube.com/bloomberg
Quicktake: https://www.youtube.com/@BloombergQuicktake

For coverage on news, markets and more: http://www.bloomberg.com/video

The post OpenAI Joins a Massive IPO Pipeline Now Worth $3.6 Trillion | Bloomberg Intelligence appeared first on MASSIVE News.

President Donald Trump’s refusal to regulate AI could put Americans at risk of attacks from biological weapons.

In an interview between CBS News contributor Chris Krebs and President Joe Biden’s former adviser Ben Buchanan (who now advises Anthropic), the two men discussed the implications for AI on biological weapons.

“I would look at these current models not as cyber models, but as generally capable models,” Buchanan told Krebs. “They can do expert tasks in a wide variety of areas, not just in cyber, also in bio and the like.” As a result, the Biden administration prioritized AI regulation, arguing that “this was something that we were very alert to in the Biden administration. There’s a long section on bio in the president’s executive order in 2023. There’s upside — AI can do a lot for medical discovery — but there also is legitimate concern that AI is outperforming PhD-level virologists on virology questions. And that could abet a bio weapons risk that is not hypothetical.”

Krebs then told Buchanan that AI is being inserted into Americans’ lives so rapidly that “we’re now entering this governance space where technology development is moving faster than democratic oversight and control can allow or provide.”

Krebs added, “They don’t really understand the technology. It’s very complex, understanding how to meaningfully intervene. That’s consistent with the American regulatory tradition — light touch, free markets, capital markets.”

Buchanan explained that the Biden administration attempted to address this because they “built a capability at the AI Safety Institute to do quick, voluntary testing of AI systems, including for cyber risk and for bio risk. So I think the tests themselves can go quickly, but that doesn’t mean the government is going to do that in a fulsome way. So the jury, I think, is still out on how the president chooses to implement this.”

Buchanan said that, despite Trump’s resistance to meaningful AI regulation, “you are seeing some interesting parallels in direction of travel that’s consistent between the administration, the Congress, and Democrats and Republicans, that understands something needs to be done. We’re just not quite sure what the mechanisms are just yet.”

Despite this push to regulate AI, The Hill’s Miranda Nazzaro wrote that “while several tech leaders are making their relations — both good and bad — with the president public, [OpenAI CEO Sam] Altman has largely kept quiet about the president and the extent of his relationship with him. It comes as OpenAI prepares an initial public offering, and Altman faces his own blowback from the anti-AI movement.” Altman and the other AI executives are reportedly pushing to keep regulations from being applied to their business.

There have been some breaks between the Trump administration and Big AI. Anthropic co-founder Dario Amodei ended up in a rift with the Trump administration after they refused to comply with Secretary of Defense Pete Hegseth’s demand that they violate their own code of ethics.

The post Trump’s refusal to regulate tech puts us in a danger we often don’t think about appeared first on MASSIVE News.